Long Term Follow up in Pediatric Supracondylar Humeral Fracture (SUPCONFOLLOW)

March 20, 2023 updated by: University Hospital, Grenoble

Long Term Follow up in Pediatric Supracondylar Humeral Fracture After Surgical Treatment

The goal of this clinical trial is to learn about long term outcomes in Supracondylar Humeral Fracture in children after surgery.

The main questions it aims to answer are:

  • how good is the elbow function
  • what are the post-operative complication
  • what is the time before return to sport
  • what is the aesthetic prejudice of the scar for the patient Participants will answer questionnaries and send photographs of their elbows to the examinator

Study Overview

Status

Not yet recruiting

Detailed Description

Elbow fractures represent 5% of total fracture in children. Supracondylar humeral fractures compound half of them.

As distal humerus is responsible for only 20% of humeral growth, bone remodelage her is less important compared to other sites in children..

Many different attitudes are possible : orthopedic reduction, open reduction, percutaneous pinning ... No methode as clearly demontrated a superiority.

Percutaneous pinning as been widely used the last years though We haven't find any study evaluating long term outcomes regarding functionnal and aesthetic outcomes in supracondylar humeral fracture treated by percutaneous pinning.

Study Type

Observational

Enrollment (Anticipated)

634

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children operated for a supracondylar humeral fracture in university hospital of Grenoble from July 2011 to December 2019

Description

Inclusion Criteria:

  • Children operated for a supracondylar humeral fracture in university hospital of Grenoble from July 2011 to December 2019

Exclusion Criteria:

  • Opposition from patient or parents to participate
  • Children who did not effectively suffered a supracondylar humeral fracture

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional outcome after supracondylar humeral fracture
Time Frame: 1 day
Pediatric-Adolescent Shoulder and Elbow Survey (PEDI ASES), rate from 0 to 84, 0 is poor and 84 is excellent
1 day
functional outcome after supracondylar humeral fracture
Time Frame: 1 day
FLYNN'S CRITERIA
1 day
functional outcome after supracondylar humeral fracture
Time Frame: 1 day
range of motion mesured in degrees
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post operative complication
Time Frame: 1 day
identify number and type of complication
1 day
time before return to sport
Time Frame: 1 day
time in days before return to sport
1 day
aesthetical prejudice
Time Frame: 1 day
The Patient and Observer Scar Assement Scale (POSAS), rate from 7 to 70, 7 is excellent and 70 is poor
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

March 1, 2023

Primary Completion (Anticipated)

January 1, 2024

Study Completion (Anticipated)

October 1, 2024

Study Registration Dates

First Submitted

March 4, 2023

First Submitted That Met QC Criteria

March 20, 2023

First Posted (Actual)

March 22, 2023

Study Record Updates

Last Update Posted (Actual)

March 22, 2023

Last Update Submitted That Met QC Criteria

March 20, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 38RC22.0384

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elbow Fracture

Subscribe